Transcatheter (percutaneous) Mitral Valve Market 2019-2023: Boston Scientific Corporation ,Abbott Laboratories ,Edwards Lifesciences Corporation,Micro Interventional Devices ,Neochord Inc. ,Medtronic, Inc – Rapid News Network
Transcatheter (percutaneous) Mitral Valve Market 2019-2023: Boston Scientific Corporation ,Abbott Laboratories ,Edwards Lifesciences Corporation,Micro Interventional Devices ,Neochord Inc. ,Medtronic, Inc – Rapid News Network
Global transcatheter was valued at US XX Mn and expected grow at XX% Compound Growth Rate (CAGR) over Transcatheter (percutaneous) Mitral 2018 2024. Transcatheter is used treat regurgitation (MR). Mitral disease is second most common valvular disease in adults. is classified as either (degenerative) or secondary (functional). Primary from degenerative disease is due disruption apparatus from either or flail on other is due remodeling left ventricle resulting coaptation Trans catheter implantation procedure helps in replacing with prosthetic for treatment severe stenosis and regurgitation. This increases survival rate patients and helps in severe degenerative stenosis. in prevalence disorders and increasing aging are expected drive.
Valve regurgitation is a structural heart disease. Regurgitation is the name for leaking heart valves. It happens when a heart’s valve does not close tightly. In patients with valve regurgitation, blood cannot move properly in the rest of the body. Valve regurgitation can be caused by problems with the heart valve such as damaged tissue cords, rheumatic fever, abnormality of the heart muscle, congenital heart defects, radiation therapy, and atrial fibrillation. Some mitral valve stenosis treatment common symptoms associated with valve regurgitation are abnormal heart sound, fatigue, swollen feet or ankles, and shortness of breath (dyspnea). Major complications associated with valve regurgitation are atrial fibrillation, heart failure, and pulmonary hypertension. Several factors can increase the risk of valve regurgitation, including a history of mitral valve prolapse or mitral valve stenosis, heart attacks, and infections such as endocarditis or rheumatic fever. Doctors can diagnose valve regurgitation based on medical history and tests.
The ESC Congress preview: European Society of Cardiology will Valve Regurgitation Diagnostic feature late-breaking clinical presentations that have the have a significant on CV care. The Congress 2019 is expected bring together 32, on the management of around the world, anticipated trials scheduled for In addition, aortic stenosis, atrial fibrillation, intervention, three sessions dedicated HF, atherosclerosis aortic stenosis.
Comments
Post a Comment